These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21516846)

  • 41. Induction of antigen-specific immunity with monoclonal anti-idiotypic antibodies in vivo: differences in potency and comparison of immunochemical properties.
    Misplon JA; Reeves JP; Harvath L; Rubinstein LJ; Epstein SL
    Eur J Immunol; 1989 Dec; 19(12):2361-5. PubMed ID: 2481592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Site-dependent production of transforming growth factor beta1 in colonic mucosa: its possible role in tumorigenesis of the colon.
    Kushiyama Y; Fukuda R; Suetsugu H; Kazumori H; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2000 Sep; 136(3):201-8. PubMed ID: 10985498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The regulation of resistance to Schistosoma mansoni by auto-anti-idiotypic immunity. II. Global qualitative and quantitative regulation.
    Phillips SM; Lin JJ; Walker DJ; Linette GP; Fathelbab NG; Perrin PJ
    J Immunol; 1990 May; 144(10):4005-10. PubMed ID: 2110216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Response of immunocompetent cells and structural changes of colon mucosa in patients with diverticulum disease].
    Levchenko SV; Gudkova RB; Potapova VB; Lazebnik LB
    Eksp Klin Gastroenterol; 2009; (5):17-20. PubMed ID: 20201300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration.
    McConnell EL; Basit AW; Murdan S
    Vaccine; 2008 Jan; 26(5):639-46. PubMed ID: 18178292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low level IGF-1 and common variable immune deficiency: an unusual combination.
    van Bilsen K; Driessen GJ; de Paus RA; van de Vosse E; van Lom K; van Zelm MC; Lam KH; Hartwig NG; Baarsma GS; van de Burg M; van Hagen PM
    Neth J Med; 2008 Oct; 66(9):368-72. PubMed ID: 18931397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibodies against nutritional antigens in IgA nephropathy].
    Nagy J; Scott H; Brandtzaeg P; Rumi G; Csermely L; Burger T; Balázs L
    Orv Hetil; 1989 Jan; 130(1):19-22. PubMed ID: 2643076
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
    Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
    Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis.
    Ebert EC; Geng X; Bajpai M; Pan Z; Tatar E; Das KM
    Am J Gastroenterol; 2009 Dec; 104(12):2996-3003. PubMed ID: 19690525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal Models of Diverticulosis: Review and Recommendations.
    Patel B; Guo X; Noblet J; Chambers S; Kassab GS
    Dig Dis Sci; 2018 Jun; 63(6):1409-1418. PubMed ID: 29679297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrous connective tissue of rat binds anti-immunoglobulin antibodies.
    Kozłowska H; Rowiński J; Bem W; Kwarecki K
    Folia Histochem Cytobiol; 1997; 35(2):123-4. PubMed ID: 9151105
    [No Abstract]   [Full Text] [Related]  

  • 52. Diverticular disease: a fresh approach to a neglected disease. Preface.
    Kruis W; Spiller RC; Papagrigoriadis S; Engel A; Kreis ME
    Dig Dis; 2012; 30(1):5. PubMed ID: 22572677
    [No Abstract]   [Full Text] [Related]  

  • 53. The microbiome and diverticulitis: a new target for medical therapy?
    Hall JF
    Dis Colon Rectum; 2014 Apr; 57(4):544-5. PubMed ID: 24608314
    [No Abstract]   [Full Text] [Related]  

  • 54. THE INCIDENCE OF COLONIC DIVERTICULOSIS IN FINLAND AND SWEDEN.
    KOEHLER R
    Acta Chir Scand; 1963; 126():148-55. PubMed ID: 14059862
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of severity of immune disorders and prognosis of the development of pyo-septic complications in patients with emergency surgery pathology].
    Bulava MM; Borovkova NV; Khvatov VB; Godkov MA
    Vestn Khir Im I I Grek; 2009; 168(3):10-6. PubMed ID: 19663272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune disorders in erosive and ulcerative lesions to the gastroduodenal mucosa].
    Maev IV; Gadzhieva MG; Ovchinnikova NI
    Klin Med (Mosk); 2004; 82(12):4-9. PubMed ID: 15732710
    [No Abstract]   [Full Text] [Related]  

  • 57. The pathology of diverticulosis: classical concepts and mucosal changes in diverticula.
    Brian West A
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S126-31. PubMed ID: 16885695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Local and systemic immunological disorders in proliferative vitreoretinopathy].
    Krivosheina OI
    Vestn Oftalmol; 2007; 123(4):51-4. PubMed ID: 17802765
    [No Abstract]   [Full Text] [Related]  

  • 59. [The role of immune system in development of structural changes in colonic mucosa in diverticulosis].
    Levchenko SV; Gudkova RB; Potapova AI; Parfenov AI; Rogozina VA; Lazebnik LB
    Ter Arkh; 2011; 83(2):29-33. PubMed ID: 21516846
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.